TBD.F - Emerald Health Therapeutics, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
Total Revenue
17,017
1,948
938
253
Cost of Revenue
26,913
5,048
1,223
603
Gross Profit
-9,896
-3,099
-286
-350
Operating Expenses
Research Development
3,941
801
208
302
Selling General and Administrative
36,549
30,448
7,295
2,133
Total Operating Expenses
43,601
34,245
8,811
2,551
Operating Income or Loss
-53,498
-37,344
-9,097
-2,901
Interest Expense
-
219
0
40
Total Other Income/Expenses Net
16,280
5,370
94
40
Income Before Tax
-35,974
-31,007
-8,842
-2,941
Income Tax Expense
-511
-24
0
0
Income from Continuing Operations
-35,462
-30,983
-8,842
-2,941
Net Income
-34,872
-30,577
-8,732
-2,941
Net Income available to common shareholders
-34,872
-30,577
-8,732
-2,941
Reported EPS
Basic
-
-0.22
-0.10
-0.05
Diluted
-
-0.22
-0.10
-0.05
Weighted average shares outstanding
Basic
-
141,443
88,448
54,265
Diluted
-
141,443
88,448
54,265
EBITDA
-
-27,341
-8,559
-2,784